Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Flipped versus traditional nivolumab plus ipilimumab dosing in patients with melanoma brain metastases. (PubMed, Eur J Cancer) - Sep 16, 2026 - "In this real-world cohort of melanoma patients with brain metastases, flipped NIVO + IPI dosing was associated with more patients completing induction and longer OS and PFS. A prospective evaluation is warranted." 
Journal • CNS Disorders • Melanoma • Oncology • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42743884
 
Anna Fager; Cissi Liu; Hildur Helgadottir; Karl Björkström; Lars Ny
 
Sep 16, 2026
 
Prev Next